This session discusses how to utilize telemedicine to treat patients with substance use disorders including regulatory compliance issues, patient engagement considerations, patient access barriers, and the need to transition systems to support virtual delivery of services.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the potential for precision medicine in methadone treatment of opioid use disorder.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about policies to improve substance use disorder treatment with telehealth during the COVID-19 pandemic and beyond.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about self-reported health diagnoses and demographic correlates with kratom use.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about co-occurring substance use disorders in youth with chronic medical conditions.

Earn 1 AMA PRA Category 1 Credit(s)™ while learning about the integration of smartphone and breathalyzer contingency management intervention for alcohol use.

ASAM is offering this new virtual experience which will provide high-quality education, innovative topics, sessions, posters and supplemental virtual courses in a completely online platform.

Education of community partners and ongoing dissemination of knowledge is an integral component of academia. Project ECHO is a novel learning and guided practice model that revolutionizes medical education and its ongoing delivery. TeleECHO™ links primary care clinicians and other providers, through a knowledge network, with an interprofessional team of specialists from an academic medical center; where expert mentors can educate and guide each other via case-based learning coupled with brief didactics. A mock ECHO session offers clinicians the freedom to learn in a non-critical environment, emphasizing real-time multidirectional feedback and encouraging knowledge and skill transfer. This session will equip participants with the ability to initiate a Project ECHO at their home institution.

What BIG IDEAS are shaping the future of addiction medicine? Draw inspiration from ASAM award recipients and insights from innovators during the Big Ideas Plenary Session.ASAM President Paul H. Earley, MD, DFASAM, will recognize award recipients with personalized video clips of individuals making major contributions to the field. Lisa A. Marsch, PhD, leading expert in behavioral health technology, will lead a lively session and discussion with representatives from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) on how these renowned agencies see digital health shaping the future of addiction medicine. Dr. Earley’s participation will offer a clinical perspective on the implications these technologies have in practice. 

Among the proliferation of technology-based 'apps' for treating substance use disorders, very few have been validated in rigorous, randomized controlled trials and have been shown to be effective in clinical populations. This session will feature the originators of three such approaches: AChess, Checkup and Choices, and CBT4CBT. Presentations will focus on the research studies evaluating these approaches, the settings and populations for which they are intended, and give a brief demonstration of each approach.